From: Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study
Pilot phase
Validation phase
RA (n = 15)
OA (n = 15)
RA (n = 47)
Non-RA (n = 48)
Mean age, years
59.3 ± 6.3
66.8 ± 10.3
57.6 ± 12.2
54.5 ± 9.2
Female sex
86.7%
73.3%
70.2%
83.3%
Symptom duration, years
4.0 ± 3.5
10.8 ± 13.9
5.3 ± 10.2
4.9 ± 5.7